Results 21 to 30 of about 70,002 (313)
Research progress on risk factors for dermatomyositis with malignancy
Pifu-xingbing zhenliaoxue zazhi, 2023 Malignant tumors are one of the major causes of mortality in patients with dermatomyositis. But the majority of these tumors are diagnosed after the diagnosis of dermatomyositis. Because the timing of diagnosis of tumor is associated with the survival of
Juanjuan PAN, Jing WANG, Guozhen TAN
doaj +1 more source
Trial of Intravenous Immune Globulin in Dermatomyositis.
New England Journal of Medicine, 2022 BACKGROUND Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not been extensively evaluated. METHODS We conducted a randomized, placebo-controlled trial involving patients with active dermatomyositis.
R. Aggarwal +29 more
semanticscholar +1 more source
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Frontiers in Immunology, 2021 Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly progressive interstitial lung disease.
Anaïs Nombel, N. Fabien, F. Coutant
semanticscholar +1 more source
Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
Medicina, 2022 Although dermatomyositis is known to be a possible paraneoplastic syndrome, often in the setting of gynecological cancers, Wong-type dermatomyositis—a rare variant of dermatomyositis—has not been clearly associated with internal malignancies to date ...
Roberto Russo +4 more
doaj +1 more source
Arthritis & Rheumatology, 2023 To describe the disease specificity, clinical phenotype, and risk of cancer in dermatomyositis (DM) patients with autoantibodies against cell division cycle and apoptosis regulator protein 1 (anti‐CCAR1).
D. Fiorentino +11 more
semanticscholar +1 more source
Enhanced immune complex formation in the lungs of patients with dermatomyositis
Respiratory Research, 2023 Background Interstitial lung disease is frequently comorbid with dermatomyositis and has a poor prognosis, especially in patients with the anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody.
Yoshiaki Zaizen +8 more
semanticscholar +1 more source
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Clinical reviews in allergy and immunology, 2022 Dermatomyositis is a chronic inflammatory disease involving the skin and muscles. It most commonly occurs in adults with preponderance in females, but pediatric occurrence is also possible.
Milena Marzęcka +2 more
semanticscholar +1 more source
JTO Clinical and Research Reports, 2021 SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti–transcription intermediary factor 1-γ (TIF1-γ ...
Johnathan Arnon, MD +4 more
doaj +1 more source
Arthritis & Rheumatology, 2020 Interstitial lung disease (ILD) accompanied by anti–melanoma differentiation–associated gene 5 (anti–MDA‐5)–positive dermatomyositis (DM) is often rapidly progressive and associated with poor prognosis.
H. Tsuji +20 more
semanticscholar +1 more source